Evidence map›Paper›PMID 40196132›Full record

ArticleFrontiers in immunology2025

Genotype-phenotype correlation in a cohort of pediatric patients with autoinflammatory diseases carrying

Marco Francesco Natale, Camilla Celani, Silvia Federici, Chiara Passarelli, Chiara Perrone, Emiliano Marasco, Fabrizio De Benedetti, Antonella Insalaco

Abstract read
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Marco Francesco NataleDivision of Rheumatology, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Camilla CelaniDivision of Rheumatology, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Silvia FedericiDivision of Rheumatology, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Chiara PassarelliLaboratory of Medical Genetics, Translational Cytogenomics Research Unit, Bambino Gesù Children Hospital, IRCCS, Rome, Italy.
Chiara PerroneLaboratory of Medical Genetics, Translational Cytogenomics Research Unit, Bambino Gesù Children Hospital, IRCCS, Rome, Italy.
Emiliano MarascoDivision of Rheumatology, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Fabrizio De BenedettiDivision of Rheumatology, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Antonella InsalacoDivision of Rheumatology, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Autoinflammatory diseases (AIDs) are a group of disease characterized by excessive activation of the innate immune system with episodes of spontaneous inflammation that can affect different organs. Many monogenic or acquired autoinflammatory diseases are described in literature. More recently the concept of disease with polygenic or complex inheritance has been introduced. Nucleotide binding oligomerization domain containing 2 (NOD2) gene variants are associated with Crohn's disease (CD), Blau syndrome and most recently with a polygenic autoinflammatory disease with onset in adult called NOD2-associated autoinflammatory disease (NAID). Objective: The aim of our study is to describe a pediatric cohort of patients with autoinflammatory disease carrying Methods: Twenty-five children with autoinflammatory disease and Results: Fever was the main clinical characteristic of our children (68%) with long episodes and irregular pattern of recurrence. The disease typically affected skin (40%), joints (72%), bowel (60%) and lymphatic system (52%). Serositis and sensorineural deafness were less frequent. Excluding non-steroidal anti-inflammatory drugs (NSAIDs), glucocorticoids were frequently used with satisfactory clinical response in the majority of patients. In patients with poor disease control or new flares after glucocorticoid tapering, non-biologic and biologic drugs were used with variable response. The comparison between the two most represented groups showed that patients with variants located on the NOD domain presented more homogeneous clinical characteristics with involvement of some target organs. Our patients were compared with the adult cohort described in literature with few differences. Conclusion: This is the first study to evaluate genotypic/phenotypic characteristics of children with systemic autoinflammatory disease and

Indexed as

Hereditary Autoinflammatory DiseasesMutationNod2 Signaling Adaptor ProteinAdolescentArthritisChildChild, PreschoolCohort StudiesFemaleGenetic Association StudiesGenetic Predisposition to DiseaseGenotypeHumansInfantMalePhenotypeNOD2 protein, humanNod2 Signaling Adaptor Proteinautoinflammatory diseaseschildrenmonogenic diseasesNOD2 genepolygenic or complex inheritance

Identifiers

PMID40196132
PMCPMC11973280

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.